Activity not yet confirmed Verified 4 Nov 2026
Guinness Global Investors
Independent London fund manager running listed equity funds. Its sister business Guinness Ventures makes Series A investments in UK scale-ups through EIS and VCT products, in business services, healthcare and consumer.
- Type
- Fund manager
- Location
- London, United Kingdom
- Stages
- Series A
- Backs
- Climate and energy, Real assets
- Sectors
- Climate and cleantech, Proptech, HR, B2B, Healthtech and life sciences, Consumer
- SEIS / EIS
- SEIS and EIS
- Website
- www.guinnessgi.com
Contacts on file
For Guinness Global Investors, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); how to pitch (the route the firm publishes); LinkedIn page.
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
Cera CarePasta EvangelistsPopsaWolf & BadgerBibliu
Sources
- www.guinnessgi.com/
- www.guinnessgi.com/contact/
- www.guinnessgi.com/about/
- www.guinnessgi.com/about/history/
- www.guinnessventures.com/
- www.guinnessgi.com/about/team/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 29 lists
Proptech investors in the UK (23)Future of work investors in London (24)Future of work investors in the UK (28)Series A future of work investors (44)Series A proptech investors (48)B2B investors in London (49)Consumer investors in London (67)Climate tech investors in London (71)B2B investors in the UK (73)SEIS funds and investors in the UK (75)Consumer investors in the UK (89)EIS funds and investors in the UK (105)Healthtech investors in London (113)Climate tech investors in the UK (146)Series A investors in the UK (154)Series A consumer investors (154)Series A B2B investors (157)Future of work investors (158)Proptech investors (159)Healthtech investors in the UK (194)Startup investors in London (239)Series A climate tech investors (263)Series A healthtech investors (401)Startup investors in the UK (416)B2B investors (438)Consumer investors (512)Climate tech investors (660)Series A investors (864)Healthtech investors (1,207)